the effects of gabapentin and paracetamol on facilitating recovery of acoronary artery bypass graft surgery

Phase 2

Recruiting

• Conditions: Surgical coronary artery bypass graft.; Presence of cardiac and vascular implant and graft, unspecified; Z95.9

• Registration Number: IRCT20200825048515N72
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 January 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Patients who are candidates for elective heart surgery
Age category above 40 years
EF>40%
American Society of Anesthesiologists (ASA) level III

Exclusion Criteria

Addiction to drugs, alcohol and industrial psychotropic substances
History of taking antipsychotic and antidepressant drugs
Having liver and kidney diseases
Allergy to paracetamol and gabapentin drugs

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood pressure. Timepoint: During operation every 15 minutes and in ICU every 1 hour. Method of measurement: Monitoring device.;Heart rate. Timepoint: During operation every 15 minutes and in ICU every 1 hour. Method of measurement: Monitoring device.;Pain. Timepoint: Post-operatively in the ICU. Method of measurement: Visual analog scale (VAS).

Secondary Outcome Measures

Name	Time	Method
ausea and vomiting. Timepoint: After surgery in recovery or ICU. Method of measurement: Observation.;Constipation. Timepoint: After surgery in recovery or ICU. Method of measurement: Observation.;Delirium. Timepoint: After surgery in recovery or ICU. Method of measurement: Observation.